Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions

被引：3
|
作者：
Wang, Norman C. [1 ]
Piccini, Jonathan P. [2 ]
Gheorghiade, Mihai [3 ]
机构：
[1] Univ Pittsburgh, Cardiovasc Inst, Med Ctr, Pittsburgh, PA 15213 USA
[2] Duke Clin Res Ctr, Durham, NC USA
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
HEART FAILURE REVIEWS | 2011年 / 16卷 / 05期
关键词：
Implantable cardioverter-defibrillator; Heart failure; Hospitalization; Mortality; VENTRICULAR EJECTION FRACTION; MYOCARDIAL-INFARCTION; SURVIVAL; HOSPITALIZATION; DEATH;
D O I：
10.1007/s10741-011-9243-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Implantable cardioverter-defibrillators have proven efficacy in reducing mortality in patients with reduced left ventricular ejection fraction in both the primary and the secondary prevention settings. All randomized trials demonstrating this benefit have been conducted in outpatients with stable heart failure symptoms. Whether implantable cardioverter-defibrillators confer a benefit when implemented in patients with chronically reduced left ventricular ejection fraction in the acute heart failure setting is unknown. The purpose of this document is to review the existing literature related to this subject.
引用
收藏
页码：477 / 480
页数：4
相关论文
共 50 条
  • [21] Implantable Cardioverter-Defibrillator Registry Risk Score Models for Acute Procedural Complications or Death After Implantable Cardioverter-Defibrillator Implantation
    Haines, David E.
    Wang, Yongfei
    Curtis, Jeptha
    CIRCULATION, 2011, 123 (19) : 2069 - 2076
  • [22] Geographic Variation in Implantable Cardioverter-Defibrillator Use and Heart Failure Survival
    Epstein, Andrew J.
    Polsky, Daniel
    Yang, Feifei
    Yang, Lin
    Groeneveld, Peter W.
    MEDICAL CARE, 2012, 50 (01) : 10 - 17
  • [23] The implantable cardioverter-defibrillator
    Greene, HL
    CLINICAL CARDIOLOGY, 2000, 23 (05) : 315 - 326
  • [24] Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator
    Klein, Helmut U.
    Goldenberg, Ilan
    Moss, Arthur J.
    EUROPEAN HEART JOURNAL, 2013, 34 (29) : 2230 - 2242
  • [25] Development of an Entirely Subcutaneous Implantable Cardioverter-Defibrillator
    Lupo, Pier Paolo
    Pelissero, Gabriele
    Ali, Hussam
    Sanghera, Rick
    Cappato, Riccardo
    PROGRESS IN CARDIOVASCULAR DISEASES, 2012, 54 (06) : 493 - 497
  • [26] Genetic polymorphisms of the adrenergic system and implantable cardioverter-defibrillator therapies in patients with heart failure
    Chemello, Diego
    Rohde, Luis E.
    Santos, Katia G.
    Silvello, Daiane
    Goldraich, Livia
    Pimentel, Mauricio
    Rosa, Priscila R.
    Zimerman, Leandro
    Clausell, Nadine
    EUROPACE, 2010, 12 (05): : 686 - 691
  • [27] Primary Prevention Implantable Cardioverter-Defibrillator Therapy in Heart Failure with Recovered Ejection Fraction
    Baman, Jayson R.
    Patil, Kaustubha D.
    Medhekar, Ankit N.
    Wilcox, Jane E.
    JOURNAL OF CARDIAC FAILURE, 2021, 27 (05) : 585 - 596
  • [28] Important Differences in Mode of Death Between Men and Women With Heart Failure Who Would Qualify for a Primary Prevention Implantable Cardioverter-Defibrillator
    Rho, Robert W.
    Patton, Kristen K.
    Poole, Jeanne E.
    Cleland, John G.
    Shadman, Ramin
    Anand, Inder
    Maggioni, Aldo Pietro
    Carson, Peter E.
    Swedberg, Karl
    Levy, Wayne C.
    CIRCULATION, 2012, 126 (20) : 2402 - +
  • [29] Mortality among ischemic and nonischemic heart failure patients with a primary implantable cardioverter-defibrillator
    Yang, Pil-Sung
    Kang, Younghyun
    Bae, Han-Joon
    Sung, Jung-Hoon
    Park, Hyung-Deuk
    Joung, Boyoung
    JOURNAL OF ARRHYTHMIA, 2021, 37 (06) : 1537 - 1545
  • [30] Prophylactic Implantation of Implantable Cardioverter-Defibrillator for Japanese Patients With Heart Failure - Problem of "Underuse"
    Kuga, Keisuke
    CIRCULATION JOURNAL, 2015, 79 (02) : 297 - 299
12345